Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Howard WW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Howard Ww
Publikováno v:
The Journal of the American Dental Association. 90:530
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Benkstein KD; Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA. Electronic address: kurt.benkstein@nist.gov., Balakrishnan G; Analytical Development and Attribute Science, Bristol Myers Squibb, New Brunswick, NJ 08901, USA., Bhirde A; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Chalus P; Lonza AG, Drug Product Services, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland., Das TK; Biologics Development, Bristol Myers Squibb, New Brunswick, NJ 08903, USA., Do N; Spectradyne LLC, 23875 Madison St Suite A, Torrance CA 90505, USA., Duewer DL; Chemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA., Filonov N; AlphaNanoTech, Morrisville, NC 27709, USA; Particle Metrix, Inc., Mebane, NC 27302, USA., Cheong FC; Spheryx, Inc., New York, NY 10016, USA., Garidel P; Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, PDB, D-88397 Biberach an der Riss, Germany., Gill NS; Yokogawa Fluid Imaging Technologies, Inc. Scarborough, ME 04074, USA., Grabarek AD; Coriolis Pharma, Fraunhoferstrasse 18 b, 82152 Martinsried, Germany; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands., Grier DG; Department of Physics and Center for Soft Matter Research, New York University, New York, NY 10003, USA., Hadley J; Malvern Pananalytical, 117 Flanders Road Westborough, MA 01581, USA., Hollingsworth AD; Department of Physics and Center for Soft Matter Research, New York University, New York, NY 10003, USA., Howard WW; Analytical Sciences, BioPharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, USA., Jarzębski M; Department of Physics and Biophysics, Faculty of Food Science and Nutrition, Poznan University of Life Sciences, Poznan, Poland., Jiskoot W; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Kar SR; Biologics Development, Bristol Myers Squibb, New Brunswick, NJ 08903, USA., Kestens V; European Commission, Joint Research Centre (JRC), Geel, Belgium., Khasa H; Analytical Sciences, BioPharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, USA., Kim YJ; Analytical Sciences, BioPharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, USA., Koulov A; Lonza AG, Drug Product Services, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland., Matter A; Lonza AG, Drug Product Services, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland., Philips LA; Spheryx, Inc., New York, NY 10016, USA., Probst C; Luminex Corporation, Seattle, WA 98119, USA., Ramaye Y; European Commission, Joint Research Centre (JRC), Geel, Belgium., Randolph TW; Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309., Ripple DC; Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA., Romeijn S; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Saggu M; Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Schleinzer F; Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, PDB, D-88397 Biberach an der Riss, Germany., Snell JR; Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309., Tatarkiewicz JK; HORIBA Scientific, Irvine, CA 92618, USA., Wright HA; Yokogawa Fluid Imaging Technologies, Inc. Scarborough, ME 04074, USA., Yang DT; Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2022 Mar; Vol. 111 (3), pp. 699-709. Date of Electronic Publication: 2021 Nov 20.
Autor:
Orozco CT; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK., Bersellini M; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Irving LM; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Howard WW; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Hargreaves D; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Devine PWA; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK., Siouve E; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK., Browne GJ; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Bond NJ; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK., Phillips JJ; Living Systems Institute, University of Exeter, Exeter, UK., Ravn P; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.; Department of Biotherapeutic Discovery, H. Lundbeck A/S, Copenhagen, Denmark., Jackson SE; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Publikováno v:
MAbs [MAbs] 2022 Jan-Dec; Vol. 14 (1), pp. 2095701.
Autor:
Calzetta L; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: luigino.calzetta@uniroma2.it., Matera MG; Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Goldstein MF; The Asthma Center, Philadelphia, PA, USA., Fairweather WR; Flower Valley Consulting, Inc. Rockville, MD, USA., Howard WW; Alitair Pharmaceuticals, Inc, Morristown, NJ, USA., Cazzola M; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Rogliani P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2020 Feb; Vol. 60, pp. 101883. Date of Electronic Publication: 2019 Dec 26.
Autor:
Calzetta L; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Hanania NA; Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA., Dini FL; Cardiopulmonary and Vascular Department, University of Pisa, Pisa, Italy., Goldstein MF; The Asthma Center, Philadelphia, PA, USA., Fairweather WR; Flower Valley Consulting, Inc., Rockville, MD, USA., Howard WW; Alitair Pharmaceuticals, Inc., Morristown, NJ, USA., Cazzola M; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: mario.cazzola@uniroma2.it.
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2018 Dec; Vol. 53, pp. 20-26. Date of Electronic Publication: 2018 Sep 13.